Work

A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors

Year: 2017

Type: article

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-017-3469-4

Authors: Vincent A. de Weger, Sanjay Goel, Roger von Moos, Jan H. M. Schellens, Nicholas Mach, Eugene Tan, Suraj Anand, Jeffrey W. Scott, Ulrik Lassen

Institutions: The Netherlands Cancer Institute, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Kantonsspital Graubünden, Utrecht University, University Hospital of Geneva, Rigshospitalet

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W2765178666

FWCI: 0.291

Cites: 26

Cited by: 4

Related to: 10